Search Results - Senthil Lingaratnam
- Showing 1 - 3 results of 3
-
1
Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review by Senthil Lingaratnam, Safeera Yasmeen Hussainy, Alexandra Murphy, Cale Perrin, Melbin Samuvel, Elahe Mehrvarz, Chiao Xin Lim, John Zalcberg
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
A systematic review and meta‐analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer by Senthil Lingaratnam, Mahek Shah, Joseph Nicolazzo, Michael Michael, John F. Seymour, Paul James, Smaro Lazarakis, Sherene Loi, Carl M. J. Kirkpatrick
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey by Sarah Glewis, Mei Krishnasamy, Senthil Lingaratnam, Sam Harris, Craig Underhill, Chloe Georgiou, Mark Warren, Robert Campbell, Maarten IJzerman, Mussab Fagery, Ian Campbell, Jennifer H. Martin, Jeanne Tie, Marliese Alexander, Michael Michael
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book